Lv4
670 积分 2022-07-06 加入
Navigating the Landscape of Reinterventions After TAVR
3天前
求助中
2023 update on the clinical management of gastroparesis
1个月前
已完结
Choosing a Prokinetic for Your Patient Beyond Metoclopramide
1个月前
已关闭
Intranasal Metoclopramide
1个月前
已完结
Extended Clopidogrel Monotherapy vs DAPT in Patients With Acute Coronary Syndromes at High Ischemic and Bleeding Risk
1个月前
已完结
Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial
1个月前
已完结
Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
2个月前
已完结
De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials
2个月前
已完结
Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial
2个月前
已完结
Clopidogrel versus aspirin for secondary prevention of coronary artery disease: a systematic review and individual patient data meta-analysis
2个月前
已完结
皖公网安备34019202002308
